A pt (b)(6) was enrolled in the (b)(6) study for stress urinary incontinence.On (b)(6) 2012, the pt was injected with 2.0 ml coaptite, lot 1032764.On the same day, the pt developed urethral swelling as a result of the coaptite injection, diagnosed by bladder ultrasound.The pt was treated with straight catheterization adn foley catheterization and recovered.Per physician, the event was of mild severity and definitely related to coaptite.On (b)(6) 2013, the pt was injected with 1.0 ml coaptite, lot 1036243.On (b)(6) 2012, the pt developed urinary tract infection diagnosed by urine culture.The pt was treated with an antibiotic treatment and recovered.Per physician, the event was of mild severity and definitely not related to coaptite.
|
Add'l lot injected: 1036243, expiration date 10/2015, manufactured 10/2012.The device history records for the reported lots were reviewed, all required testing specs were met prior to release, there were no abnormalities noted.
|